Becton Dickinson, a medical technology company, completed the acquisition of Venclose, a provider of solutions for the treatment of chronic venous insufficiency. Financial terms were not disclosed. "Our acquisition of Venclose will enable us to offer a more robust portfolio of solutions to physicians who are treating the full range of venous conditions. The Venclos RF Ablation System strategically complements our category-leading portfolio of venous disease technologies and aligns with our focus on innovations that provide transformative solutions to improve outcomes for chronic disease and enable the transition into new care settings," Paddy O'Brien, Becton Dickinson President.